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1. Introduction 
Acetylsalicylic acid has been shown previously to 
transfer its acetyl group under physiological con- 
ditions in vitro and in vivo to the e-amino group of a 
specific lysine residue of human serum albumin, 
thereby increasing the ability of this protein to bind 
the anionic drug acetriozate [ 1,2]. A peptide in a 
tryptic digest of this acetylated human serum albumin 
has been identified by fingerprinting techniques as 
being that containing the modified lysine residue and 
was found to contain two lysine residues (one of 
which was acetylated) [3,4]. However, the reported 
amino acid composition of this peptide [3,4] does 
not correspond to that of any peptide which could 
be expected from this tryptic digest on the basis of 
either the amino acid sequence of this protein as 
described by Behrens et al. [5] or of that somewhat 
different version of the sequence of this protein as 
described by Meloun, Mor~ivek and Kostka [6]. 
In view of this anomaly it was decided to reisolate 
this modified peptide and to determine its amino 
acid sequence and to thereby establish the identity 
of an amino acid residue in one of the binding sites 
of the albumin molecule. 
2. Materials and methods 
2.1. Protein and chemicals 
Human serum albumin (Fraction V powder, fatty 
acid free) was from Miles Laboratories Inc., Elkhorn, 
Indiana, USA, and TLCK-treated trypsin was from 
Worthington Biochemical Corp., Freehold, N. J., USA 
[1-t4C]acetylsalicylic acid (10.8 mCi/mmol, > 98% 
pure) was purchased from the Radiochemical Centre, 
Amersham, UK. Iodoacetic acid was recrystallised 
from hexane. All other chemicals were of the highest 
available purity. 
2.2. Determination of radioactivity 
Radioactivities were measured in a Nuclear Chicago 
Unihx I scintillation counter in Bray's solution [7]. 
2.3. Amino acid analysis 
Protein and peptides were hydrolysed in vacuo 
with 6 N HCI containing 0.1% phenol for 24 h. 
Hydrolysates were analysed with a Durrum D-500 
analyser. 
2.4. Reaction of  human serum albumin with [1-14C] 
acetylsalicylic acid 
This was performed as described earlier [3]. Human 
serum albumin (70 mg, 1.1/aM) was dissolved in 
sodium phosphate buffer (6 ml, 0.1 M, pH 7.4) and 
[1-14C] acetylsalicylic a id (5.8/aM, 60/aCi) dissolved 
in chloroform (25/al) added. This solution was then 
incubated at 37°C for 24 h and then dialysed against 
three changes of a buffer (1 litre) containing 0.15 M 
NaC1 and 0.01 M sodium salicylate and finally against 
0.5% ammonium bicarbonate. The specific radio- 
activity of the modified protein was determined by 
measurements of the radioactivity of portions of the 
protein solution and by measurement of the protein 
concentration byamino acid analysis of hydrolysates 
of portions of this solution. 
2.5. Carboxymethylation 
After reaction with [ 1-14C] acetylsalicylic a id, 
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albumin was reacted with iodoacetic acid as follows. 
The protein (70 mg) was dissolved under nitrogen in 
50 mM Tris-HCl (pH 8.2, 6 ml) containing 6 M 
guanidinium hydrochloride. After 15 rain dithio- 
threitol (28 mg, 180 taM) was added followed 1 h 
later by the addition of iodoacetic acid (134 mg, 
70 taM). After 1 h this solution was dialysed against 
ammonium bicarbonate solution (10 mM) and 
freeze-dried. 
2.6. Digestion with trypsin 
This was performed in 1% ammonium bicarbonate 
solution, pH 8.4, containing 2 M guanidinium 
hydrochloride at37°C using a trypsin-modified 
albumin ratio (w/w) of 1: 50. After 4 h the reaction 
mixture was freeze-dried. 
2.7. Peptide #actionation 
The tryptic digest of modified human serum albumin 
was fractionated on a column of Sephadex G.50 
(superfine) (100 X 2.5 cm i.d.) in 0.5% ammonium 
bicarbonate buffer. The absorbance at225 nm of the 
effluent was monitored with a Cecil 272 ultraviolet 
spectrophotometer with a flow cell (5 mm path length). 
Fractions of 2.7 ml were collected. The radio- 
activities of portions of each fraction were determined. 
Certain fractions from this column were freeze dried 
and then fractionated further by high voltage paper 
electrophoresis at pH 6.5 and 2.1 at 60 V/cm on 
Whatman No. 1 paper [8]. Radioactive peptides were 
detected by overnight radioautography using Kodak 
Autoprocess AP-54 film. Peptides were eluted from 
paper with 1% ammonia. 
2.8. The dansyl-Edman method 
This was carried out as described by Hartley [9]. 
Dansyl amino acids were identified by chromato- 
graphy on polyamide sheets (Schleicher and Schfill) 
[9] following hydrolysis of dansylated peptides at 
110 ° C for 4 h in vacuo. 
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Fig.1. Gel filtration on Sephadex G-50 (superfine) of a tryptic 
digest of human serum albumin previously modified by reac- 
tion with [ 1-14C]acetylsalicylic a id. The protein was reduced 
and S-carboxymethylated prior to digestion with trypsin as 
described in Materials and methods. ( ) Absorbance at 
225 nm; (- - - • - - -) radioactivity. For details see Materials 
and methods. 
located in one peak of the elution prof'fle resulting 
from the fractionation of the tryptic digest of the 
transacetylated S-carboxymethyl uman serum 
albumin (fig.l). Only one radioactive peptide was 
detected in this fraction by autoradioautography 
following high voltage paper electrophoresis at 
pH 6.5 and 2.1. The amino acid analysis of the radio- 
active peptide showed that it included two lysine 
residues and 1 carboxymethylcysteine residue in its 
composition. Sequence analysis bf this peptide 
demonstrated that radioactivity was associated with 
the lysine residue at position 2 of the peptide (table 1). 
This peptide corresponds toresidues 198-205 of 
human serum albumin as determined by Meloun, 
Mor~ivek and Kostka [6]. The corresponding residue 
in the sequence described by Behrens et al. was 
assigned as arginine [5]. 
3. Results 
The radioactivity incorporated into human serum 
following transacetylation with [1-~4C] acetylsalicylic 
acid, 2.7 × l0 s cpm/tamol f albumin corresponds to
the reaction of 1.1 taM of acetylsalicylic a id/taM of 
albumin. The majority (85%) of this radioactivity was 
4. Discussion 
The human serum albumin molecule appears to 
contain a number of binding sites which enable it to 
bind an extraordinarily wide range of chemical 
substances [10]. The aeetylation of human serum 
174 
Volume 66, number 2 FEBS LETTERS 
Table 1 
Properties of the major adioactive tryptic peptide isolated from human 
serum albumin following reaction with [ 1-t4C]acetylsalicylic a id 
Property determined Result 
Amino acid composition 
Mobility at pH 6.5 
Charge 
Amino acid sequence 
CMCyso.9, Sert.o, Glut.o, Alal.o, Leut.9, Lyst.s 
0 
0 
Leu- Lys-CMCys-Ala-Ser- Leu-Gin- Lys 
- -7  denotes equence determined by dansyl-Edman method. At each stage of the 
degradation a portion of the peptide was removed and its radioactivity sub- 
sequently measured. After removal of the second amino acid residue the peptide 
was no longer adioactive. 
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albumin with acetylsalicylic acid has been shown 
previously to profoundly affect the ability of this 
protein to bind various anionic compounds. Thus, 
the binding of acetriozate [1,2,4] and phenylbutazo'ne 
[11 ] is enhanced and concomitantly with the latter 
observation flufenamic acid binding is decreased. 
Further, salicylate and acetriozate prevent he trans- 
acetylation reaction and moreover, acetriozate binding 
is inhibited by a variety of drugs [4]. The transfer of 
an acetyl group from acetylsalicylic acid to the 
e-amino groups of a lysine residue of human serum 
albumin is thus a convenient method of chemically 
labelling a specific amino acid residue in one of the 
binding sites of this protein and has here enabled lysine 
residue 199 to be identified as being in this site. It 
appears that this site is distinct from the tryptophan 
binding site which contains histidine residue 146 [12], 
since tryptophan does not inhibit salicylate binding 
[4]. 
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